Clinical Trials
Clinical Studies in Portugal
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Location
Unidade Local de Saude de Braga, EPE /ID# 275394 (Braga, Portugal)
Gender
ALL
Age
18 Years or more
Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1
Location
Hospital Prof. Doutor Fernando Fonseca E.P.E. (Amadora, Portugal)
Gender
ALL
Age
18 Years or more
Nuclear Magnetic Resonance for Embryo Ploidy Selection
Location
Instituto Valenciano de Infertilidade (Lisbon, Portugal)
Gender
FEMALE
Age
Between 18 Years and 48 Years
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy
Location
Centro Clinico Academico - Hospital de Braga (Braga, Portugal)
Gender
ALL
Age
18 Years or more
Measuring Self-Efficacy on Portuguese Respiratory Patients on Pulmonary Rehabilitation
Location
Instituto Nacional de Saúde Doutor Ricardo Jorge, Departamento de Epidemiologia (Lisbon, Portugal)
Gender
ALL
Age
Between 26 Years and 89 Years
The Motor Neurological Soft Signs (MNSS) in Persons With Schizophrenia
Location
Susana Guimarães (Lisbon, Portugal)
Gender
ALL
Age
18 Years or more
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
Location
Hospitais da Universidade de Coimbra (Coimbra, Portugal)
Gender
FEMALE
Age
18 Years or more
Propofol Pharmacokinetics and Pharmacodynamics Modelling
Location
Centro Hospitalar do Porto (Porto, Portugal)
Gender
ALL
Age
18 Years or more
Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
Location
Hospital de Braga (Braga, Portugal)
Gender
ALL
Age
18 Years or more
To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
Location
Site Number - 3742 (Senhora da Hora, Portugal)
Gender
ALL
Age
18 Years or more